Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Arcturus Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2013 · IPO 2017 Thoroughbred

Global late-stage clinical messenger RNA medicines company

Valuation
$39M
Market cap · May/2026
Revenue
$67M
Latest reported FY

Global footprint

Where Arcturus Therapeutics has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States97.9%
🏳️ Somalia0.7%
🇳🇱 Netherlands0.7%
🇮🇹 Italy0.7%
4 countries shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States58.9%
🏳️ Korea14.2%
🏳️ Republic of7.9%
🇯🇵 Japan6.8%
🇬🇧 United Kingdom5.8%
Top 5 markets shown

Market sentiment

What the market is saying about Arcturus Therapeutics

An AI-synthesized read of the highest-engagement posts about Arcturus Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arcturus Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.